CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −31,910 | $55.00 | $1.8M | 2,925,573 |
| 2024-02-28 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −28,090 | $55.00 | $1.5M | 41,981 |
| 2024-02-27 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −62,810 | $55.00 | $3.5M | 3,043,619 |
| 2024-02-27 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −29,491 | $55.00 | $1.6M | 2,957,483 |
| 2024-02-27 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −29,431 | $55.00 | $1.6M | 70,071 |
| 2024-02-21 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −1,125 | $55.27 | $62K | 3,106,429 |
| 2024-02-21 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −509 | $55.31 | $28K | 2,986,974 |
| 2024-02-21 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −569 | $55.30 | $31K | 99,502 |
| 2024-02-20 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $57.45 | $575K | 2,987,483 |
| 2024-02-20 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $57.43 | $574K | 100,071 |
| 2024-02-20 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −20,000 | $57.44 | $1.1M | 3,107,554 |
| 2024-02-16 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −20,000 | $60.15 | $1.2M | 3,127,554 |
| 2024-02-16 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $60.15 | $602K | 2,997,483 |
| 2024-02-16 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $60.15 | $602K | 110,071 |
| 2024-02-15 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −20,000 | $60.18 | $1.2M | 3,147,554 |
| 2024-02-15 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $60.17 | $602K | 3,007,483 |
| 2024-02-15 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $60.16 | $602K | 120,071 |
| 2024-02-14 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $62.42 | $624K | 3,017,483 |
| 2024-02-14 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −10,000 | $62.43 | $624K | 130,071 |
| 2023-12-20 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −5,264 | $58.34 | $307K | 520,903 |
Page 5 of 10 · 184 trades